Galena Biopharma Inc - GALE - Financial Statement Analysis

All financial statement analysis reports for your requested company can be accessed below. The SIC # column is the SIC Code for the industry under which the current company is analyzed. When a report is purchased the SIC Code indicated is the industry that the company displayed will be compared against. If a different industry is desired for comparison, purchase of a separate industry analysis is suggested.

In addition to the ratio analysis reports, the latest business news headlines involving your company or industry sector are hyperlinked for your convenience along with the stock ticker for the company displayed.

Financial statement analysis updated: May 26, 2013

Galena Biopharma Inc - SIC # 8731

Ticker	Exchange	SIC #	Website	Latest Ticker
GALE	Nasdaq	8731	http://www.galenabiopharma.com/	2.56 -0.04
Select one of the five (5) financial statement analysis reports below to view the ratio analysis report for your selected company: Publicly Traded Company Industry Ratios Publicly Traded Company VS. Industry Ratios Publicly Traded Company VS Publicly Traded Company Private Company VS Publicly Traded Company
Latest Headlines for Galena Biopharma Inc Galena Biopharma to Present at the 2013 Marcum MicroCap Conference - May 23rd, 2013 5:05 am A Journey To Add Biotech To The Portfolio - May 18th, 2013 12:38 am GALENA BIOPHARMA, INC. Financials - May 17th, 2013 11:04 am GALENA BIOPHARMA, INC. Files SEC form 8-K, Changes in Registrant's Certifying Accountant, Financial Statements and Ex - May 16th, 2013 8:16 am Galena Targets Cancer Pain Market - May 15th, 2013 10:19 am Alexza Pharmaceuticals: A Teva Partnership Of Immense Meaning - May 15th, 2013 3:17 am Galena Biopharma: Stock First, Science Second? - May 13th, 2013 12:01 pm VIDEO RELEASE -- Galena Biopharma Reports First Quarter 2013 Financial Results - May 9th, 2013 2:05 pm GALENA BIOPHARMA, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Ex - May 9th, 2013 7:11 am Galena Biopharma's Abstral serves as model for TIRF REMS program - May 9th, 2013 5:33 am Galena Biopharma Poster Presentation at the American Pain Society 32nd Annual Scientific Meeting - May 9th, 2013 5:05 am Galena: Improving Cancer Vaccines for the Future - May 7th, 2013 1:50 pm Top Small-Cap Biotech Stocks Being Accumulated By Large Fund Managers - May 7th, 2013 1:38 pm 2 Biotechs To Avoid, 1 To Buy - May 4th, 2013 8:29 am 3 Stocks Near 52-Week Highs Worth Selling - May 2nd, 2013 11:54 am GALENA BIOPHARMA, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibi - May 2nd, 2013 4:27 am William L. Ashton Joins Galena Biopharma's Board of Directors - May 1st, 2013 5:25 am William L. Ashton Joins Galena Biopharma's Board of Directors - May 1st, 2013 5:05 am 2 Biopharmaceutical Companies Worth Buying - Apr 29th, 2013 8:39 am Galena Biopharma to Present at the 12th Annual Needham Healthcare Conference - Apr 24th, 2013 5:40 am View All Current Headlines >>